Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Sickness behavior in humans is characterized by low mood and fatigue, which have been suggested to reflect changes in motivation involving reorganization of priorities. However, it is unclear which specific processes underlying motivation are altered. We tested whether bacterial endotoxin E. coli lipopolysaccharide (LPS) affected two dissociable constructs of motivational behavior, ie effort and reward sensitivity. After familiarization with 5 effort levels, participants made a series of accept/reject decisions on whether the stake offered (1, 4, 8, 12 or 15 apples)) was 'worth the effort' (10, 27.5, 45, 62.5 and 80% of maximal voluntary contraction in a hand-held dynamometer). Effort and reward levels were parametrically modulated to dissociate their influence on choice. 29 healthy young males were administered LPS (2 ng/kg; n=14) or placebo (0.9% saline; n=15). The effort-stake task, and self-reported depression and fatigue were assessed prior to LPS/Placebo injection, 2 and 5 h post-injection. Cytokines and sickness symptoms were assessed hourly till 8 h after LPS injection. LPS transiently increased IL6 and TNFα, sickness symptoms, body temperature and self-reported fatigue and depression post-injection relative to baseline and placebo. These changes were accompanied by LPS-induced decreases in acceptance rates of high effort options, without significantly affecting reward sensitivity 2 h post-injection which were partially recovered 5 h post-injection. We suggest that LPS-induced changes in motivation may be due to alterations to mesolimbic dopamine. Our behavioral paradigm could be used to further investigate effects of inflammation on motivational behavior in psychiatric and chronic illnesses.Neuropsychopharmacology accepted article preview online, 26 September 2017. doi:10.1038/npp.2017.231.

Original publication

DOI

10.1038/npp.2017.231

Type

Journal article

Journal

Neuropsychopharmacology

Publication Date

26/09/2017